To diagnose Alzheimer’s disease, the most critical biological indicators are total tau, phosphorylated tau isoforms (P-Tau231 and P-Tau 181), and β-amyloid peptide [29]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.